Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

In Vitro Drug Release Testing: Overview, Development and Validation

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Translational Regulation

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Choice of oncologist and influencing factors: analysis of the Pancreatic Cancer Action Network registry.

The oncologist·2025

Same author

Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer.

Journal of the National Cancer Institute·2025

Same author

The Contribution of Cirrhosis Progression in Liver Dysfunction After Stereotactic Body Radiation Therapy.

International journal of radiation oncology, biology, physics·2025

Same author

Utility-Based Dose Selection for Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.

International journal of radiation oncology, biology, physics·2025

Same author

Sequential <sup>90</sup>Y Selective Internal Radiation Therapy (SIRT) and Stereotactic Body Radiation Therapy (SBRT) using <sup>90</sup>Y PET-based Absorbed Dose Maps: Interim Analysis of a Phase 1 Study.

Advances in radiation oncology·2025

Same author

Identifying signs and symptoms of pancreatic cancer: a population-based study using electronic health records and natural language processing.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2025

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

The Translational Research Working Group developmental pathway for interventive devices.

Gary S Dorfman¹, Theodore S Lawrence, Lynn M Matrisian

¹Weill Cornell Medical College, New York, New York, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

|September 17, 2008

Summary

This research outlines the interventive device pathway for developing novel cancer ablation technologies. It details the process from initial concept to clinical validation, aiming to improve cancer treatment device development.

More Related Videos

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

Published on: June 17, 2022

Related Experiment Videos

Last Updated: Jul 1, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

Published on: June 17, 2022

Area of Science:

Oncology
Biomedical Engineering
Medical Device Development

Background:

Translational research in oncology is structured into six core pathways.
The interventive device pathway specifically addresses the development of medical devices for localized cancer ablation.
Existing challenges in real-world device development necessitate clear guidelines.

Purpose of the Study:

To describe the unique characteristics of the interventive device pathway.
To identify and discuss challenges encountered during the development of interventive cancer devices.
To propose the pathway as a flexible framework for optimizing device development.

Main Methods:

Review and description of the interventive device pathway's stages.
Analysis of real-world issues in cancer device development.
Framework proposal for development, optimization, testing, and validation.

Main Results:

The interventive device pathway provides a structured approach for cancer device development.
Key challenges in real-world application and validation are identified.
The pathway serves as a dynamic guideline for improving device efficacy.

Conclusions:

The interventive device pathway offers a comprehensive roadmap for developing localized cancer ablation devices.
Addressing identified challenges can enhance the efficiency and effectiveness of new therapeutic technologies.
This framework supports the advancement of translational cancer research through device innovation.